Galactose

DB11735ApprovedInvestigationalWithdrawnSmall molecule

Galactose has been used in trials studying the treatment and diagnosis of Hepatitis C, Hepatic Cancer, Wilsons Disease, Diabetic Macular Oedema, and Focal Segmental Glomerulosclerosis, among others. There are even... There are even proposals for its use in accelerating senescence in mice, rats, and Drosophila, for its association with ovarian cancer, or even for the potential treatment of focal segmental glomerulosclerosis.

Chemical structure of Galactose
Mechanism
Curator reviewed · 11 references
Primary indication
There are limited therapeutic uses for which galactose is formally indicated.Curator reviewed
Formula / weight
C6H12O6 · 180.1559 g/mol (avg)
First approval
Canada, 1998
Also known as
D-Galactose

Resolves to

Structure
InChIKeyGZCGUPFRVQAUEE-KCDKBNATSA-NSMILES[H]C(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO
Transporters

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
15Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Marketed productsAcross 1 country and 1 labeller
Sign in
2ATC codesIncluding every combination product, plus 7 drug categories
Sign in
22+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Galactose, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account